A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of ULTRACET (tramadol HCl/acetaminophen) [tramadol/paracetamol] for the Treatment of Acute Low Back Pain.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of ULTRACET (tramadol HCl/acetaminophen) [tramadol/paracetamol] for the Treatment of Acute Low Back Pain.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 04 May 2010

At a glance

  • Drugs Tramadol/paracetamol (Primary)
  • Indications Back pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 May 2009 Planned end date changed from May 2005 to Apr 2005 as reported by ClinicalTrials.gov.
    • 26 May 2009 Actual patient number (22) added as reported by ClinicalTrials.gov.
    • 29 Jun 2007 Status changed from recruiting to discontinued.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top